Hematology/Blood Disorders

FDA Grants Market Clearance for the OrSense NBM200;  the First Noninvasive Hemoglobin System Cleared for Use in  Blood Donation Centers

FDA Grants Market Clearance for the OrSense NBM200; the First Noninvasive Hemoglobin System Cleared for Use in Blood Donation Centers

OrSense Ltd., a leading developer of systems for non-invasive measurements of Hemoglobin, today announces that its NBM200 non-invasive Hemoglobin measurement device has received FDA/CBER 510(K) clearance for use in blood banks. The OrSense NBM200 device provides painless, reliable and efficient…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login